Skip to content

Diagnostic and Prognostic Prediction Models for Chinese Patients With Venous Thromboembolism

The DOMESTIC Study: Diagnostic and Prognostic Prediction Models for Patients With Venous Thromboembolism in China

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03802929
Enrollment
4000
Registered
2019-01-14
Start date
2019-06-01
Completion date
2024-12-31
Last updated
2019-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Thromboembolism (VTE)

Brief summary

The objective of this proposal is to develop and validate diagnostic and prognostic (including short-term and long-term prognoses) prediction models for patients with venous thromboembolism (VTE) in China.

Detailed description

Venous thromboembolism (VTE), which clinically manifests as deep vein thrombosis (DVT) and pulmonary embolism (PE), is one of the leading causes of mortality that need to be accurately diagnosed and effectively managed. Although a number of clinical decision rules in the domain of VTE have been presented in the literature, such as the well-known prediction models developed by Wells and colleagues, the prognostic models to assess VTE recurrence risk in patients who suffered from a VTE or the Pulmonary Embolism Severity Index (PESI) for short-term mortality risk in PE patients, and various other diagnostic models for both DVT and PE. They are few designed for Chinese patients. The primary objective of this proposal is to develop and validate diagnostic and prognostic (including short-term and long-term prognoses) prediction models for patients with VTE in China.

Interventions

None listed

Sponsors

Nanfang Hospital, Southern Medical University
CollaboratorOTHER
First Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
Ya-Wei Xu
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. \> 18 years old 2. First episode of PE and/or DVT (diagnosed by pulmonary angiogram, chest computed tomography pulmonary angiography(CTPA), Ventilation/Perfusion (V/Q) lung scan read as high probability by the radiologist, and/or (+) bilateral lower limb venous compression ultrasonography (CCUS))

Exclusion criteria

1. Patients with prior VTE 2. Cannot provide written informed consent 3. Unable to read questionnaire in Chinese or English 4. a record of pregnancy in the preceding 12 months

Design outcomes

Primary

MeasureTime frameDescription
Death from all causes5-yearDeath from all causes during follow-up

Secondary

MeasureTime frameDescription
Number of Participants with Recurrent VTE5-yearRecurrent symptomatic DVT confirmed by venography or color duplex sonography or recurrent symptomatic pulmonary embolism confirmed by ventilation-perfusion scanning, CTPA, or pulmonary angiogram.
Number of Participants with Chronic Thromboembolic Pulmonary Hypertension(CTEPH)5-yearCTEPH can be diagnosed by an echocardiogram or a CTPA.

Other

MeasureTime frameDescription
Number of Participants with Cardiogenic Shock30-dayCardiogenic shock defined as hemodynamic instability(systolic blood pressure\<90 mm Hg, or use of inotropic support)

Countries

China

Contacts

Primary ContactDachun Xu, Ph.D
xdc77@tongji.edu.cn0086-18917684045
Backup ContactFan Wang, MD
15216717487@163.com0086-15216717487

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026